Microorganisms evolve via a range of mechanisms that may include or involve sexual/parasexual reproduction, mutators, aneuploidy, Hsp90 and even prions. Mechanisms that may seem detrimental can be repurposed to generate diversity. Here we show that the human fungal pathogen Mucor circinelloides develops spontaneous resistance to the antifungal drug FK506 (tacrolimus) via two distinct mechanisms. One involves Mendelian mutations that confer stable drug resistance; the other occurs via an epigenetic RNA interference (RNAi)-mediated pathway resulting in unstable drug resistance. The peptidylprolyl isomerase FKBP12 interacts with FK506 forming a complex that inhibits the protein phosphatase calcineurin 1 . Calcineurin inhibition by FK506 blocks M. circinelloides transition to hyphae and enforces yeast growth 2 . Mutations in the fkbA gene encoding FKBP12 or the calcineurin cnbR or cnaA genes confer FK506 resistance and restore hyphal growth. In parallel, RNAi is spontaneously triggered to silence the fkbA gene, giving rise to drug-resistant epimutants. FK506-resistant epimutants readily reverted to the drug-sensitive wild-type phenotype when grown without exposure to the drug. The establishment of these epimutants is accompanied by generation of abundant fkbA small RNAs and requires the RNAi pathway as well as other factors that constrain or reverse the epimutant state. Silencing involves the generation of a double-stranded RNA trigger intermediate using the fkbA mature mRNA as a template to produce antisense fkbA RNA. This study uncovers a novel epigenetic RNAi-based epimutation mechanism controlling phenotypic plasticity, with possible implications for antimicrobial drug resistance and RNAi-regulatory mechanisms in fungi and other eukaryotes.
Microorganisms evolve via a range of mechanisms that may include or involve sexual/parasexual reproduction, mutators, aneuploidy, Hsp90 and even prions. Mechanisms that may seem detrimental can be repurposed to generate diversity. Here we show that the human fungal pathogen Mucor circinelloides develops spontaneous resistance to the antifungal drug FK506 (tacrolimus) via two distinct mechanisms. One involves Mendelian mutations that confer stable drug resistance; the other occurs via an epigenetic RNA interference (RNAi)-mediated pathway resulting in unstable drug resistance. The peptidylprolyl isomerase FKBP12 interacts with FK506 forming a complex that inhibits the protein phosphatase calcineurin 1 . Calcineurin inhibition by FK506 blocks M. circinelloides transition to hyphae and enforces yeast growth 2 . Mutations in the fkbA gene encoding FKBP12 or the calcineurin cnbR or cnaA genes confer FK506 resistance and restore hyphal growth. In parallel, RNAi is spontaneously triggered to silence the fkbA gene, giving rise to drug-resistant epimutants. FK506-resistant epimutants readily reverted to the drug-sensitive wild-type phenotype when grown without exposure to the drug. The establishment of these epimutants is accompanied by generation of abundant fkbA small RNAs and requires the RNAi pathway as well as other factors that constrain or reverse the epimutant state. Silencing involves the generation of a double-stranded RNA trigger intermediate using the fkbA mature mRNA as a template to produce antisense fkbA RNA. This study uncovers a novel epigenetic RNAi-based epimutation mechanism controlling phenotypic plasticity, with possible implications for antimicrobial drug resistance and RNAi-regulatory mechanisms in fungi and other eukaryotes.
The pathogenic fungus M. circinelloides grows as hyphae aerobically, and as yeast in low oxygen and high-CO 2 conditions 3 . FKBP12 is a prolyl isomerase conserved throughout eukaryotes that interacts with FK506 and rapamycin and mediates their antifungal activity in M. circinelloides 4 and other fungi. The FKBP12-FK506 and FKBP12-rapamycin complexes inhibit the protein phosphatase calcineurin and the Tor kinase, respectively 1, 5 . FK506 inhibition of calcineurin blocks hyphal growth of M. circinelloides and enforces yeast-phase growth 2 (Fig. 1a and Extended Data Fig. 1a ). Exposure to FK506 yields drug-resistant isolates exhibiting hyphal growth emerging from the yeast colony periphery (Extended Data Fig. 1a ) at a ratio of one resistant isolate out of ,1 3 10 6 yeast cells. A subset of FK506-resistant (FK506 r ) isolates harbour mutations in the fkbA gene encoding FKBP12 or the calcineurin A or B subunit genes cnaA and cnbR (45 of 64 isolates (,70%), Supplementary Table 1) 
However, several FK506 r isolates (17 of 64 (,27%)) harboured no mutations in the fkbA or calcineurin target genes. These isolates exhibited resistance to FK506 and rapamycin, but not to cyclosporin A (CsA, which, similar to FK506, enforces largely yeast growth, Fig. 1a ) or other drugs (nystatin, amphotericin B, not shown), suggesting that they had not developed multidrug resistance mechanisms. These unusual drugresistant isolates also reverted frequently within several generations of vegetative growth on drug-free media and were restored to a wild-type phenotype (yeast growth on exposure to FK506) (Extended Data Fig. 1b, c) . Expression analyses revealed a complete loss of fkbA mRNA and FKBP12 protein in these drug-resistant isolates when grown in media containing FK506. In contrast, mRNA and protein levels were reduced but detectable in some resistant isolates when grown in drug-free media (Fig. 1b , c) and were restored to wild-type levels in revertant isolates that became FK506-sensitive (FK506 s ) following growth in drug-free media (Fig. 1b As drug resistance was reversible and an active RNAi pathway is present in the organism 6, 7 we hypothesized that drug resistance is RNAimediated. Notably, small RNAs (sRNAs) complementary to fkbA were detected in these unusual drug-resistant isolates ( Fig. 2a and Extended Data Fig. 2a ), suggesting a new role for RNAi in the development of transient resistance to antifungal drug exposure. Consistent with the expression analyses, the sRNA signal was highly abundant during growth with FK506 (100%), less abundant when the isolates were grown in drug-free media (,62% and ,25% for epimutant strains EM2 and EM3, respectively, Fig. 2a ) and lost when drug resistance reverted (0-0.02%). The fkbA silencing was not associated with DNA methylation in M. circinelloides (Extended Data Fig. 2b ). We term these unusual drug-resistant isolates epimutants, by analogy with studies in fungi 8, 9 , plants 10 and animals [11] [12] [13] , in which epimutations have been described as silencing of genes that are usually active, or vice versa 11 .
Our first hypothesis was that RNAi could be triggered via doublestrand RNA (dsRNA) production from the overlap in the 39 regions between fkbA and its convergently transcribed neighbouring gene patA (Extended Data Fig. 3 and Supplementary Table 2 ). But patAD mutants did not show any effect on the frequency of fkbA epimutational silencing (Table 1 , Supplementary Table 1 and Extended Data Fig. 4 ). 39 rapid amplification of cDNA end assays confirmed that the mRNA from fkbA gene and the pyrG marker replacing patA were not overlapping (Supplementary Table 2 ). Thus, expression of patA to generate overlapping RNA molecules is not necessary for fkbA silencing.
As fkbA is a highly expressed gene (Fig. 1c) , and a high RNA turnover rate has been implicated in the production of aberrant RNA and triggering of silencing [14] [15] [16] [17] , we speculated that an fkbA antisense RNA may be generated by an RNA-dependent RNA polymerase (RdRP) 18 . Northern blot analysis with an fkbA antisense-specific probe revealed an antisense fkbA mRNA in all strains with robust fkbA expression ( Fig. 1c ). This fkbA antisense RNA is perfectly complementary to the intron-spliced mature fkbA sense mRNA, and is 59 capped and polyadenylated (Extended Data Fig. 5 ). Thus, the antisense RNA is generated from the mature fkbA mRNA. The fkbA antisense RNA is expressed in the wild-type strain ( Fig. 1c) ; however, RNAi is activated in only a subset of cells selected with FK506. The in vivo efficiency of dsRNA formation or its transport to the cytoplasm may limit sRNA levels restricting silencing to fewer cells. Only traces of antisense sRNAs complementary to fkbA (16 reads) were detected in the wild-type strain by high-throughput sequencing (Extended Data Fig. 6 ), supporting this hypothesis.
To test if mutations may have occurred to promote the formation of epimutations, the reverted and now sensitive epimutant strains were exposed to a second round of FK506 to isolate mutants/epimutants. The frequency of epimutation versus mutation to FK506 r in the reverted epimutant strains was similar or even lower than in the parental wild-type strain (Extended Data Fig. 7 ). Thus, the underlying mechanism appears solely epigenetic and does not require any genetic change in the genome to promote epimutation.
High-throughput sequencing demonstrated abundant sRNAs complementary to the fkbA mRNA (antisense) as well as sense sRNA in three epimutant resistant isolates, but these were barely detectable in the wildtype strain or in the two corresponding FK506 s revertants analysed ( Fig. 2b ). Some sRNA sequences spanned exon-exon junctions ( Fig. 2b and Extended Data Fig. 8a ), indicating that the source and target of the sRNA is mature mRNA. Most of these sRNAs average 21-24 nucleotides in length, with a bias towards 59 terminal uridine ( Fig. 2c ), features typical of sRNAs that interact with Argonaute proteins. No further loci were detected exhibiting the same pattern of sRNA production: high level in epimutants and very low levels in wild-type and reverted strains (Extended Data Fig. 8b ). Silencing pathways can operate constitutively on M. circinelloides endogenous genes during normal growth 7 . In contrast, a, sRNAs were extracted from wild-type, epimutants (FK506 and R lanes) and reverted strains (S lanes) after growth in YPD media alone (R, S lanes) or with FK506 (FK506 lanes). sRNAs (25 mg) were analysed by sRNA blot employing an antisense-specific probe for the fkbA gene or a probe for 5S rRNA (loading control). Images representative of three independent experiments. b, The presence of sense and antisense fkbA sRNA was analysed by highthroughput sequencing in wild-type, epimutants and two revertant strains (EM1-S and EM3-S). sRNA amount is expressed in reads per million, and they are distributed along the fkbA open reading frame (bottom). c, Analysis of size and first nucleotide (inset) of antisense sRNAs. The representation corresponds to data obtained from isolate EM1-R. Similar results were observed for the EM2-R and EM3-R epimutants. 
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the FK506-selected silencing of the fkbA gene may not affect other loci. However, no other phenotypes were selected and sRNAs are often lost without selection ( Fig. 2a and Extended Data Figs 1b and 8b). To test if silencing was driven and enhanced by a genome-wide increase in stress-activated RNAi, the wild-type strain was exposed to stress conditions before FK506 exposure ( Supplementary Table 3 ). However, analysis of recovered FK506 r isolates did not show an increase (or decrease) of epimutation frequency in fkbA ( Supplementary Table 4 ). Thus, either stress fails to activate RNAi or we have not identified the precise activating stress. The calcineurin inhibitor CsA also did not increase epimutations conferring FK506 resistance; thus inhibition of calcineurin (by CsA or FK506) does not activate RNAi.
To investigate if sRNAs generated against fkbA are produced by canonical RNA silencing, we screened for epimutants in mutants lacking RNAi pathway components. No epimutants were found in dcl2, ago1 or rdrp2 mutants ( Table 1 and Extended Data Fig. 9a ), showing that Dcl2 (Dicer), Ago1 (Argonaute) and RdRP2 are necessary for endogenous silencing of fkbA. Dcl2 and Ago1 are essential for both transgene-induced and endogenous silencing in M. circinelloides 7, 19, 20 . RdRP2 is essential to amplify RNAi signals for transgene-induced silencing 18 , but was thought to play a role secondary to RdRP1 for endogenous RNAi silencing 7 . Instead, we find RdRP2 is crucial, suggesting that different pathways for endogenous silencing operate in M. circinelloides, which may be correlated with the four different known classes of exonic siRNA (ex-siRNA) 7 . Notably, we found only one epimutant in two independent dcl1 mutants (1 of 46 FK506 r isolates, 2.2%, Table 1 , Supplementary Table 1 and Extended Data Fig. 9a ). Dcl1 is not known to have any essential role in transgeneinduced or endogenous silencing 7,21 , but does have an auxiliary function in mutants lacking Dcl2 (ref. 19 ). The paucity of fkbA epimutants in the dcl2 and dcl1 mutant backgrounds suggests that both Dcl1 and Dcl2 are involved in epimutational fkbA silencing. ago2 and ago3 mutants exhibited a wild-type frequency of silencing (15-17%, Table 1 and Extended Data Figs 9a and 2a), thus Ago2 and Ago3 are dispensable for epimutation 20 . These results reveal that establishment of epimutants in M. circinelloides depends on Dcl2, Dcl1, Ago1 and RdRP2. Except for Dcl1, these genes are involved in biogenesis of the known class I type of ex-siRNA 7 . Thus, although epimutant genetic requirements could suggest that a distinct sRNA class is involved (given the role of Dcl1), we cannot exclude the possibility that fkbA silencing is due to an atypical class I ex-siRNA.
Unexpectedly, our studies revealed a novel role for RdRP1 in constraining epimutational silencing. RdRP1 is required for RNA silencing of exogenous sense transgenes in M. circinelloides. When DNA alleles producing dsRNA are introduced, this bypasses RdRP1 to evoke gene silencing 18 . As noted above, RdRP1 has a major role in endogenous silencing 7 . RdRP1 is hypothesized to be central for activating RNAi by generating dsRNA from the single-stranded RNA (ssRNA) precursor, both from sense transgenes or mRNA. In this model, RdRP1 should be essential for triggering fkbA silencing because it involves an fkbA dsRNA ( Fig. 1c and Extended Data Fig. 5) . Surprisingly, the rdrp1 mutant showed an elevated silencing rate of ,80% (versus ,22% in wild-type, Table 1 and Extended Data Fig. 9a and 2a ) and the epimutants isolated in this mutant did not revert on drug-free media (epimutant strain EM4, Extended Data Fig. 1b ). In Caenorhabditis elegans the rrf-3 mutant lacking one of several RdRPs has a similar enhanced RNAi phenotype 22, 23 . RRF-3 has also been proposed to generate dsRNA from mRNA templates 24 , hence RdRP1 and RRF-3 could serve analogous roles. Furthermore, the exosome and RNAi pathways in Schizosaccharomyces pombe compete in their degradation activities. Both mechanisms share common targets 25 , and in the rdp1 mutant sRNA formation is abolished and mRNAs are primarily directed to the exosome 26 . In Mucor, RdRP1 could have an opposing role to RNAi, promoting assembly of exosome machinery on specific mRNA targets and thereby avoiding activation of RNAi under normal conditions, as was suggested previously 7 .
To test which RdRP might generate dsRNA from fkbA mRNA, we tested for fkbA antisense RNA in silencing mutants (Extended Data Fig. 9b ). All strains analysed expressed the antisense RNA at similar levels, even in the rdrp1 and rdrp2 mutants. The two RdRP polymerases could have a redundant role in generating fkbA antisense RNA (rdrp1 rdrp2 double mutants appear inviable, precluding analysis, not shown), or other rdrp genes may participate.
Together these results provide evidence for a different route for the processing of endogenous sRNA, wherein RdRP2, Ago1 and both Dcl proteins are necessary to silence mRNA expression via epimutation, and RdRP1 has an unexpected role constraining epimutational silencing. We consider two possible models. In the first, sRNAs are produced constitutively and stochastically at low levels against the entire genome or some designated loci, allowing adaptation to environments through an RNAibased pathway. In the second model, some mechanism activates RNAi under adverse or novel physiological conditions, facilitating genomic and phenotypic plasticity. Either could explain the broad range of environments in which M. circinelloides grows, and the limited antifungal drug susceptibility.
Previous studies showed that the M. circinelloides species complex includes three distinct subspecies: M. circinelloides f. lusitanicus, M. circinelloides f. circinelloides, and M. circinelloides f. griseocyanus 27 . Mating barriers and phylogenetic separation provide evidence that these three lineages are different enough to represent distinct species. To generalize our findings, two M. circinelloides f. circinelloides strains (Mucho, 1006PhL 28 ), and an M. circinelloides f. griseocyanus strain (ATCC1207a) were tested in addition to the M. circinelloides f. lusitanicus strains. Only the M. circinelloides f. circinelloides strains grew as yeast in the presence of FK506 (Extended Data Fig. 10a ), enabling the recovery of FK506 r isolates. The two M. circinelloides f. circinelloides strains exhibited different patterns of genomic plasticity; FK506 r isolates appeared earlier in 1006PhL than Mucho (5-7 days versus 5-15 days) and 2.5-fold more isolates were recovered from 1006PhL (Supplementary Table 5 ). Epimutants silencing fkbA occurred in the pathogenic isolate 1006PhL at a surprisingly higher rate (90%) than in Mucho (,7.7%) or the M. circinelloides f. lusitanicus strains (,20-30%) (Supplementary Table 5 and Extended Data Fig. 10b ). M. circinelloides f. circinelloides is the most common Mucor species associated with human infection. The enhanced ability to activate RNAi exhibited by the 1006PhL virulent isolate suggests that RNAi may enable this fungal pathogen to readily adapt both in nature and the host. Further studies are required to elucidate whether our observations are generally applicable, or if not, how specificity is brought about.
This study underscores the ability of M. circinelloides to adapt to the environment through two different routes of phenotypic variation, one stable (mutation) and one transient (epimutation). This plasticity evokes a broader phenotypic repertoire including the ability to reverse epimutations when selective pressures are relaxed. This is, to our knowledge, the first known example of epimutations involving an endogenous gene in fungi identified in a standard genetic screen; however, given the ubiquity of RNAi it is unlikely to be unique. While this example involves resistance to an antifungal drug in a human fungal pathogen, these findings could have implications beyond novel modes of transient antimicrobial resistance for the broader evolutionary trajectory of this and other eukaryotes with active RNAi pathways.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Strains and growth conditions. The leuA leucine auxotrophic strain R7B, derived from M. circinelloides f. lusitanicus CBS277.49 (syn. Mucor racemosus ATCC1216b), was used as the wild-type strain to compare with the patA and silencing mutant strains, as they were generated in the R7B background [18] [19] [20] [21] . Strain NRRL3631 is used as wild type in the rest of the experiments. The strains were grown at room temperature (,26 uC) on yeast extract peptone dextrose agar (YPD, 10 g l 21 yeast extract, 20 g l 21 4 peptone, 20 g l 21 dextrose, 2% agar), MMC medium pH 5 4.5 (1% casamino acids, 0.05% yeast nitrogen base without amino acids and ammonium sulphate, 2% glucose), or YNB minimal medium 29 pH 4.5, supplemented with 1 mg ml 21 of FK506 (Prograf), 100 ng ml 21 of rapamycin, or 100 mg ml 21 of CsA when needed. The cultures were routinely incubated for 48 h except when noted otherwise or for the isolation of FK506-resistance patches, when the cultures were incubated for as long as 4 weeks in some cases. The media to test the different stress conditions was prepared by adding the specific compounds at the concentrations indicated (see Supplementary Table 3 ) except for trisporic acid, which was sprayed over the spores (approximately 100 mg of trisporoid as suggested by previous studies 30 ). All of the compounds were added to YPD medium unless otherwise specified. FK506-resistant strain isolation. FK506 r isolates were obtained after growing the different strains on YPD containing 1 mg ml 21 of FK506 for 3 days to 3-4 weeks at room temperature, until patches with hyphal growth were observed. Each isolate was derived from an independent subculture grown on a different Petri dish. The isolates were analysed after at least three generations of vegetative growth in the presence of FK506 to ensure a high proportion of the nuclei in the mycelium syncytium were mutant or silenced. DNA/RNA extraction and analysis. The isolates were grown on MMC media pH 5 4.5, supplemented with 1 mg ml 21 of FK506 when necessary, before DNA or RNA purification. The FKBP12 gene fkbA and calcineurin genes cnaA, cnaB, cnaC and cnbR were sequenced from DNA purified with CTAB and chloroform extraction from lyophilized mycelia. The FK506-resistant isolates obtained in a mutant background were verified by junction PCR for the deletion of the proper gene. Small and total RNAs were extracted using Trizol as described previously 6 from frozen mycelia in liquid nitrogen. 25-35 mg of sRNAs were separated by electrophoresis on 15% TBE-Urea gels (Invitrogen), electrotransferred to Hybond N1 filters at 400 mA for 1 h in 0.5X TBE, and cross-linked by irradiation with ultraviolet irradiation (2 pulses at 1.2 3 10 5 mJ per cm 2 ). Prehybridization and hybridization were carried out with ultrasensitive hybridization buffer UltraHyb (Ambion). The fkbA antisense-specific and 5S rRNA riboprobes were prepared by in vitro transcription using the Maxiscript transcription kit (Ambion) following supplier-recommended protocols. Riboprobes were treated as described previously 6 to result in an average size of 50 nucleotides (nt). Protein cell extracts and analysis. Whole-protein cell extracts were prepared from mycelia grown on MMC media pH 5 4.5 and frozen in liquid nitrogen as described previously 31 with some modifications. The sample was ground to a powder with a mortar and pestle and transferred to TSA extraction buffer (10 mM Tris-HCl pH 5 8.0 and 0.15 M NaCl) with protease inhibitors (complete Mini from Roche), and 1 mM of benzamidine. After 30 min incubation on ice and 30 min centrifugation at top speed at 4 uC, the amount of protein in the supernatant was quantified by Bradford assay (BioRad). Protein (100-120 mg) was loaded in 4-20% polyacrylamide gels for western blot analysis. Antiserum against ScFKBP12 raised in rabbits 32 was used to detect FKBP12 in Mucor, as this serum was previously shown to be cross-reactive 4 . Mouse monoclonal antibodies against a-tubulin (Sigma, T5168) served as the loading control. Disruption of patA. A disruption allele containing the pyrG gene as a selectable marker flanked by sequences 59 and 39 of the patA open reading frame (ORF) was generated via overlap PCR and used to generate patA null mutants by gene replacement. Primers used for the construction of the disruption allele and the confirmation of the deletion are listed in Supplementary Table 6 . Strain MU402 (leuA 2 , pyrG 2 ) was transformed with the patAD::pyrG disruption cassette as described previously 33 by electroporation of protoplasts obtained from spores after treatment with chitosanase and lysing enzymes. 59 and 39 junction PCRs were used to identify transformants in which homologous replacement of the patA locus had occurred and confirmed with both spanning and ORF-specific PCR analysis. 39 and 59 rapid amplification of cDNA end (RACE) assays. Total RNA for 39 and 59 RACE assays was extracted following the protocol for filamentous fungi supplied with the RNeasy Plant Mini Kit (QIAGEN). The FirstChoice RLM-RACE kit (Ambion) was used for 39 and 59 untranslated region (UTR) amplification and the gene-specific primers used are listed in Supplementary Table 6 . Sequences were aligned with Serial-Cloner software. High-throughput sRNA sequencing. sRNA libraries were prepared following the instructions of the TruSeq Small RNA Sample Prep Kit (Illumina). sRNA-enriched samples extracted with the mirVana miRNA isolation kit (Ambion) as previously described 7 were size-fractioned by electrophoresis and the 18-24 nt fraction purified from the gel was used as input. The library was sequenced by the High-Throughput Sequencing Facility (HTSF), UNC Chapel Hill, using the Illumina platform (HiSeq  2000) .
Raw sRNA sequences were processed using fastx_clipper (http://hannonlab.cshl. edu/fastx_toolkit/) to remove adaptor sequences. The adaptor sequences trimmed from each sample are listed in Supplementary Table 7 . Because samples were multiplexed for sequencing, each sample was trimmed using a multiplex index-specific sequence. The adaptor sequences that were trimmed are based on those supplied by the manufacturer (Oligonucleotide sequences, Illumina, Inc.). Trimmed reads were then mapped to the Mucor circinelloides CBS277.49 v2.0 genome 34 using TopHat 35 (TopHat version 2.0.5, Bowtie version 2.0.0.7, Samtools version 0.1.18.0) and the basic library data are represented in Supplementary Table 8 . The downloaded genome annotation file was modified to include the coordinates of the 39 UTRs for the patA and fkbA genes as determined by 39 RACE (see Supplementary Table 2 ); this modified annotation file served as the input for TopHat.
Both parts of Fig. 2c represented the antisense reads of fkbA from the EM1-R samples, and show reads that map entirely within the fkbA gene (1803250-1803768 on scaffold_03). Figure 2b presents all reads that map to the fkbA gene, and the read counts were normalized to the total number of mapped reads in the sample.
Extended Data Fig. 8a shows a map for all of the reads in the EM1-R sample, emanating from the region of the exon 1-exon 2 boundary of the fkbA gene (that is, reads completely within the range 1803668-1803774 on scaffold_03). Only reads with at least five copies in the sample are shown.
Extended Data Fig. 6 consists of the sequence logos 36 for all fkbA antisense reads (plus strand in the range 1803250-1803768 on scaffold_03) in the wild-type sample, at each read length observed.
Figures 2b, c and Extended Data Figs 6 and 8a were generated using custom software, based on a number of existing software libraries [36] [37] [38] [39] [40] [41] . The analysis and figures can readily be reproduced by downloading the source code from https://bitbucket. org/granek/mucor_srna. Raw data from the high-throughput sRNA sequencing of wild-type, epimutant and revertant strains have been deposited in NCBI's Gene Expression Omnibus 42 and are accessible through accession number GSE56353.
To search for genes with sRNA patterns correlated with fkbA (Extended Data Fig. 8b ), antisense read counts were determined for each annotated gene using htseqcount 43 , counts were normalized using the R package DESeq2 38 , and genes with counts so low (mean normalized count across samples less than 10) that any true differences between samples are confounded by Poisson noise were excluded from consideration. The similarity to fkbA was determined by computing the Kendall rank correlation coefficient for each annotated gene in the genome. The fifty genes with the highest correlation coefficient (that is, most closely correlated with fkbA) were plotted using R 44 for comparison to fkbA. GenBank accession numbers. Sequences for the fkbA and calcineurin genes from the wild-type strain NRRL3631 and the epimutant strains (EM1, EM2 and EM3) were deposited in GenBank with accession numbers wild-type fkbA, KF203228; EM1 fkbA, KF203229; EM2 fkbA, KF203230; EM3 fkbA, KF203231; wild-type cnaA, KJ668831; wild-type cnaB, KJ668832; wild-type cnaC, KJ668833; wild-type cnbR, KJ668834; EM1 cnaA, KJ668835; EM1 cnaB, KJ668836; EM1 cnaC, KJ668837; EM1 cnbR, KJ668838; EM2 cnaA, KJ668839; EM2 cnaB, KJ668840; EM2 cnaC, KJ668841; EM2 cnbR, KJ668842; EM3 cnaA, KJ668843; EM3 cnaB, KJ668844; EM3 cnaC, KJ668845; and EM3 cnbR, KJ668846. P value calculation. P values listed in Table 1 are based on a Fisher's exact probability test for a 2 by 2 contingency table, comparing each of the patA and silencing mutant strains individually versus the R7B WT strain, from which all of the mutants were generated. by two mechanisms, one stable (mutation) and one transient (epimutation). a, The wild-type strain (NRRL3631) grows as hyphae (white, upper left panel) on YPD and as a yeast (yellow, upper centre panel) on YPD containing 1 mg ml 21 of FK506. An FK506-resistant patch that emerged from the south-eastern edge of the yeast patch is shown after 10 days of incubation (arrow, upper right panel). Microscopic images corresponding to the culture plates at the top were taken at different incubation periods as indicated and are shown in the lower panels. For yeast growth, cells from the colony were dispersed in water on a microscope slide. The black patch (arrow) in the microscopic image in the lower right panel corresponds to the edge of the compact yeast colony. Images are representative of all of the FK506-resistant isolates obtained (see Supplementary Tables 1, 3 and 5) . b, Epimutant strains revert during passage on drug-free media. Y, yeast; H, hyphal. Shaded areas indicate reversion of epimutants to the wild-type phenotype (yeast growth on YPD supplemented with 1 mg ml 21 FK506). SM2 strain 4 harbours an A-to-G substitution (A316G) in the acceptor splice site of intron 2. Darker vertical bars indicate intervals in which some passages are not depicted. c, Reverted epimutant strains from b lost their resistance to FK506 and rapamycin (central panels) and remained sensitive to CsA whose mechanism of action does not involve FKBP12 (right panel). The images were taken after 48 h of incubation at room temperature (,26 uC) on YPD or YPD media supplemented with the different drugs. Images are representative of two independent experiments. EM1-S, EM2-S and EM3-S, epimutants 1, 2 and 3 reverted to restore FK506-sensitivity; fkbAD, fkbA null mutant.
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Extended Data Figure 2 | Epimutations are generated by the RNAi pathway, and are not associated with DNA methylation in M. circinelloides. a, Confirmation of the presence of sRNAs in all of the remaining epimutant isolates from the different strains lacking mutations in the fkbA and calcineurin genes (cnaA, cnaB, cnaC and cnbR) not shown in Fig. 2a or Extended Data Fig. 9 . The numbers of the isolates correspond to those in Supplementary  Table 1 . sRNA blots were hybridized with an antisense-specific probe to detect fkbA sRNA. 5S rRNA served as a loading control. Abundant sRNAs were detected in all of the strains with the exception of three of the isolates (NRRL3631 isolate 9, R7B isolate 8 and MU410 isolate 26). These isolates also do not show any mutations in the genes analysed (fkbA, cnaA, cnaB, cnaC and cnbR) and the mechanism by which they have developed FK506-resistance remains to be established. C1, EM1. The image of the blot in which these three isolates were included is representative of two independent experiments. All of the other blots were generated only once, because a positive signal indicates the presence of sRNA. b, Genomic DNA (,40 mg) from the wild-type strain (NRRL3631), the three epimutants (1, EM1; 2, EM2; 3, EM3), and the three reverted strains (1-S, EM1-S; 2-S, EM2-S; 3-S, EM3-S) was treated with the methylated-DNA-specific restriction enzyme McrBC (NEB) with or without previous treatment with the CpG methyltransferase SssI (NEB), following the manufacturer's protocols. PCR amplification of the fkbA locus (,1. 
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Extended Data Figure 7 | Reverted strains (EM1-S, EM2-S and EM3-S) exposed to a second round of FK506 selection undergo epimutations at the same frequency as the wild-type strain. Epimutant strains (EM1, EM2 and EM3) that had reverted to an FK506-sensitive wild-type phenotype (yeast growth in the presence of FK506) after several passages on drug-free media were exposed a second time to 1 mg ml 21 FK506 to ascertain if genomic mutations had occurred that enhance epimutant formation. a, The numbers of the isolates correspond to those in Supplementary Table 1 . The new FK506 r isolates that lacked a Mendelian mutation in any of the target genes showed abundant sRNAs complementary to fkbA based on northern blot of sRNA hybridized with an fkbA antisense-specific probe. 5S rRNA served as a loading control. Images are representative of two independent experiments. EM1-S, EM2-S and EM3-S, epimutants 1, 2 and 3 reverted to restored FK506sensitivity; C1, EM1 before reversion of FK506-resistance. b, The frequency of epimutation was similar or lower in the reverted epimutant strains compared to the wild type, which suggests that no mutations arose promoting epimutation. In addition, because rdrp1 mutations enhance epimutation frequency and stability, the rdrp1 gene was sequenced in EM3 and found to be wild-type with no mutations. P values were obtained based on a Fisher's exact probability test for a 2 by 2 contingency table, comparing each of the mutant strains individually versus the wild-type strain NRRL3631.
Extended Data Figure 8 | sRNAs were detected by high-throughput sequencing in the epimutant strains, but not in the wild-type and reverted strains. This pattern was not conserved in any other loci in the genome. a, sRNAs were found to span exon-exon junctions. Antisense and sense sRNAs from EM1 that span intron 1 are shown at the top and bottom, respectively. The numbers on the left are the normalized read counts (reads per million) for each specific sRNA. Only sRNAs with five or more read counts are shown. The reference sequence is in red and sRNAs spanning the intron are in black. b, Distribution of antisense sRNA for the fkbA gene across the different strains and the 50 genes with sRNA patterns most closely correlated with fkbA. sRNA read count distribution for the fkbA gene is represented with a heavy grey line (left panel). The 50 genes with the closest correlated pattern are represented with thin colored lines. The bottom part of the left panel has been expanded to elucidate the read count patterns of the correlated genes (right panel). While some of these genes show an apparent similarity to the pattern of sRNA in the fkbA silenced and revertant strains, the levels of read counts are in most cases ,100-fold lower than that for the fkbA gene, and were not detected by sRNA blots (data not shown). WT, strain NRRL3631; EM1-R, EM2-R and EM3-R, epimutants 1, 2 and 3 resistant to FK506; EM1-S and EM3-S, epimutants 1 and 3 reverted to restored FK506 sensitivity.

